diabetes with the time, motivation and resources to utilize complex, expensive products. As a result, these entities have largely neglected the approximately one million people in the United States who still rely on daily injections for treatment. Modular seeks to expand the insulin delivery marketplace to these underserved patients, so they can benefit from Modular's advanced technology to assist in their care.